ZITHROMAX

Zithromax Adverse Events Reported to the FDA Over Time

How are Zithromax adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zithromax, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zithromax is flagged as the suspect drug causing the adverse event.

Most Common Zithromax Adverse Events Reported to the FDA

What are the most common Zithromax adverse events reported to the FDA?

Diarrhoea	240 (1.67%)
Drug Ineffective	221 (1.54%)
Vomiting	210 (1.46%)
Nausea	208 (1.45%)
Rash	176 (1.23%)
Pyrexia	175 (1.22%)
Dyspnoea	170 (1.19%)
Abdominal Pain	135 (.94%)
Hypersensitivity	134 (.93%)
Headache	132 (.92%)
Urticaria	129 (.9%)
	Show More
Drug Hypersensitivity	119 (.83%)
Drug Interaction	117 (.82%)
Pneumonia	114 (.79%)
Malaise	113 (.79%)
Abdominal Pain Upper	104 (.73%)
Anxiety	99 (.69%)
Pruritus	98 (.68%)
Weight Decreased	92 (.64%)
Stevens-johnson Syndrome	91 (.63%)
Loss Of Consciousness	89 (.62%)
Fatigue	85 (.59%)
Dizziness	84 (.59%)
Deafness	82 (.57%)
Cough	80 (.56%)
Asthenia	79 (.55%)
Pain	78 (.54%)
Anosmia	76 (.53%)
Rhabdomyolysis	76 (.53%)
Tinnitus	76 (.53%)
Condition Aggravated	75 (.52%)
Ageusia	70 (.49%)
Feeling Abnormal	70 (.49%)
Alanine Aminotransferase Increased	65 (.45%)
Aspartate Aminotransferase Increase...	65 (.45%)
Convulsion	64 (.45%)
Erythema	61 (.43%)
Insomnia	61 (.43%)
Medication Error	56 (.39%)
Tremor	55 (.38%)
Chest Pain	54 (.38%)
Bronchitis	52 (.36%)
Cardiac Arrest	52 (.36%)
Liver Disorder	51 (.36%)
Oedema Peripheral	51 (.36%)
Anaphylactic Shock	50 (.35%)
Shock	50 (.35%)
Drug Eruption	49 (.34%)
Abdominal Discomfort	48 (.33%)
C-reactive Protein Increased	48 (.33%)
Dysgeusia	48 (.33%)
Hypoaesthesia	47 (.33%)
Chills	45 (.31%)
Palpitations	45 (.31%)
Blood Pressure Decreased	44 (.31%)
Electrocardiogram Qt Prolonged	43 (.3%)
Asthma	42 (.29%)
Heart Rate Increased	42 (.29%)
Sinusitis	42 (.29%)
Dysphagia	41 (.29%)
Hepatic Function Abnormal	41 (.29%)
Interstitial Lung Disease	41 (.29%)
Pancytopenia	41 (.29%)
Tachycardia	41 (.29%)
Decreased Appetite	40 (.28%)
Dehydration	40 (.28%)
Haematochezia	40 (.28%)
Somnolence	39 (.27%)
Swelling Face	39 (.27%)
Viral Infection	38 (.26%)
Drug Exposure During Pregnancy	37 (.26%)
Myalgia	36 (.25%)
Anorexia	35 (.24%)
Death	35 (.24%)
Nasopharyngitis	35 (.24%)
Pallor	35 (.24%)
Rash Generalised	35 (.24%)
Renal Failure	35 (.24%)
Swelling	35 (.24%)
Arthralgia	34 (.24%)
Confusional State	34 (.24%)
Renal Impairment	34 (.24%)
Blood Pressure Increased	33 (.23%)
Hallucination	33 (.23%)
Infection	33 (.23%)
Blister	32 (.22%)
Chromaturia	32 (.22%)
Conversion Disorder	32 (.22%)
Delirium	32 (.22%)
Paraesthesia	32 (.22%)
Depression	31 (.22%)
Pain In Extremity	31 (.22%)
Blood Alkaline Phosphatase Increase...	30 (.21%)
Blood Creatinine Increased	30 (.21%)
Blood Glucose Increased	30 (.21%)
Jaundice	30 (.21%)
Respiratory Arrest	30 (.21%)
Anaemia	29 (.2%)
Eating Disorder	29 (.2%)
Muscle Spasms	29 (.2%)
Stomatitis	29 (.2%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Zithromax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zithromax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zithromax

What are the most common Zithromax adverse events reported to the FDA?

Epidermal And Dermal Conditions	908 (6.33%)
Gastrointestinal Signs	856 (5.97%)
Neurological	656 (4.57%)
Respiratory	597 (4.16%)
Infections - Pathogen Unspecified	556 (3.88%)
Therapeutic And Nontherapeutic Effe...	396 (2.76%)
Allergic Conditions	350 (2.44%)
Hepatic And Hepatobiliary	322 (2.24%)
Gastrointestinal Motility And Defec...	302 (2.11%)
Cardiac Arrhythmias	290 (2.02%)
Hematology Investigations	266 (1.85%)
	Show More
Hepatobiliary	239 (1.67%)
Cardiac And Vascular Investigations	229 (1.6%)
Medication Errors	228 (1.59%)
Body Temperature Conditions	209 (1.46%)
Muscle	187 (1.3%)
Anxiety Disorders	183 (1.28%)
Hearing	164 (1.14%)
Oral Soft Tissue Conditions	156 (1.09%)
Headaches	150 (1.05%)
Angiedema And Urticaria	138 (.96%)
Physical Examination Topics	137 (.96%)
Lower Respiratory Tract Disorders	132 (.92%)
Renal Disorders	132 (.92%)
Upper Respiratory Tract Disorders	132 (.92%)
Viral Infectious	130 (.91%)
Movement Disorders	124 (.86%)
Bacterial Infectious	119 (.83%)
Cranial Nerve Disorders	119 (.83%)
Anemias Nonhemolytic And Marrow Dep...	117 (.82%)
Urinary Tract Signs	117 (.82%)
Seizures	115 (.8%)
Electrolyte And Fluid Balance Condi...	104 (.73%)
Inner Ear And Viiith Cranial Nerve	103 (.72%)
Bronchial Disorders	102 (.71%)
Gastrointestinal Hemorrhages	99 (.69%)
Decreased And Nonspecific Blood Pre...	96 (.67%)
Musculoskeletal And Connective Tiss...	95 (.66%)
Vision	93 (.65%)
Sleep Disorders	92 (.64%)
Appetite And General Nutritional	90 (.63%)
Joint	88 (.61%)
Administration Site Reactions	86 (.6%)
Injuries	85 (.59%)
Tongue Conditions	83 (.58%)
Vascular	81 (.56%)
Cardiac Disorder Signs	79 (.55%)
Metabolic, Nutritional And Blood Ga...	79 (.55%)
Eye	77 (.54%)
Ocular Infections, Irritations And ...	77 (.54%)
Deliria	76 (.53%)
Disturbances In Thinking	75 (.52%)
Enzyme	74 (.52%)
Protein And Chemistry Analyses	73 (.51%)
Skin Appendage Conditions	73 (.51%)
Chemical Injury And Poisoning	63 (.44%)
Renal And Urinary Tract Investigati...	63 (.44%)
Gastrointestinal Inflammatory Condi...	60 (.42%)
Fungal Infectious	59 (.41%)
Aural	57 (.4%)
White Blood Cell	57 (.4%)
Water, Electrolyte And Mineral	54 (.38%)
Skin Vascular Abnormalities	52 (.36%)
Fatal Outcomes	51 (.36%)
Lifestyle Issues	51 (.36%)
Mental Impairment	49 (.34%)
Gastrointestinal Conditions	47 (.33%)
Platelet	44 (.31%)
Depressed Mood Disorders	43 (.3%)
Lipid Analyses	42 (.29%)
Glucose Metabolism Disorders	41 (.29%)
Vascular Hemorrhagic	39 (.27%)
Coronary Artery	38 (.26%)
Spleen, Lymphatic And Reticulendoth...	37 (.26%)
Dental And Gingival Conditions	35 (.24%)
Psychiatric	34 (.24%)
Coagulopathies And Bleeding Diathes...	32 (.22%)
Encephalopathies	32 (.22%)
Pleural	32 (.22%)
Psychiatric And Behavioural Symptom...	32 (.22%)
Somatoform And Factitious	32 (.22%)
Toxicology And Therapeutic Drug Mon...	32 (.22%)
Eating Disorders	30 (.21%)
Heart Failures	30 (.21%)
Therapeutic Procedures And Supporti...	30 (.21%)
Mood Disorders	29 (.2%)
Salivary Gland Conditions	29 (.2%)
Personality Disorders	28 (.2%)
Vulvovaginal Disorders	26 (.18%)
Exocrine Pancreas Conditions	25 (.17%)
Product Quality Issues	25 (.17%)
Central Nervous System Infections A...	24 (.17%)
Vascular Inflammations	24 (.17%)
Glaucoma And Ocular Hypertension	23 (.16%)
Suicidal And Self-injurious Behavio...	23 (.16%)
Tendon, Ligament And Cartilage	23 (.16%)
Vascular Hypertensive	23 (.16%)
Procedural And Device Related Injur...	22 (.15%)
Gastrointestinal Ulceration And Per...	21 (.15%)
Hematological And Lymphoid Tissue T...	20 (.14%)
Hemolyses And Related Conditions	20 (.14%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zithromax, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zithromax is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.